{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T05:17:57Z","timestamp":1790054277575,"version":"4.0.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"Hellenic Institute for the Study of Sepsis"},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["01EO1002"],"award-info":[{"award-number":["01EO1002"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13054-017-1625-1","type":"journal-article","created":{"date-parts":[[2017,3,6]],"date-time":"2017-03-06T10:38:22Z","timestamp":1488796702000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Decreased cytokine production by mononuclear cells after severe gram-negative infections: early clinical signs and association with final outcome"],"prefix":"10.1186","volume":"21","author":[{"given":"Nikolaos","family":"Antonakos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Tsaganos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volker","family":"Oberle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iraklis","family":"Tsangaris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malvina","family":"Lada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aikaterini","family":"Pistiki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos","family":"Machairas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Souli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelos J.","family":"Giamarellos-Bourboulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,9]]},"reference":[{"key":"1625_CR1","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/CCM.0000000000000026","volume":"42","author":"EK Stevenson","year":"2014","unstructured":"Stevenson EK, Rubenstein AR, Radin GT, Wiener RS, Walkey AJ. Two decades of mortality trends among patients with severe sepsis: a comparative meta-analysis. Crit Care Med. 2014;42:625\u201331.","journal-title":"Crit Care Med"},{"key":"1625_CR2","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/nri3552","volume":"13","author":"RS Hotchkiss","year":"2013","unstructured":"Hotchkiss RS, Monneret G, Payen D. Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nat Rev Immunol. 2013;13:862\u201374.","journal-title":"Nat Rev Immunol"},{"issue":"Suppl","key":"1625_CR3","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.ijantimicag.2010.11.003","volume":"36","author":"EJ Giamarellos-Bourboulis","year":"2010","unstructured":"Giamarellos-Bourboulis EJ. What is the pathophysiology of the septic host upon admission? Int J Antimicrob Agents. 2010;36(Suppl):S2\u20135.","journal-title":"Int J Antimicrob Agents"},{"key":"1625_CR4","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1128\/CMR.00016-12","volume":"25","author":"K Reinhart","year":"2012","unstructured":"Reinhart K, Bauer M, Riedemann NC, Hartog CS. New approaches to sepsis: molecular diagnostics and biomarkers. Clin Microbiol Rev. 2012;25:609\u201334.","journal-title":"Clin Microbiol Rev"},{"key":"1625_CR5","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1001\/jama.2011.1829","volume":"306","author":"JS Boomer","year":"2011","unstructured":"Boomer JS, To K, Chang KC, Takasu O, Osborne DF, Walton AH, et al. Immunosuppression in patients who die of sepsis and multiple organ failure. JAMA. 2011;306:2594\u2013605.","journal-title":"JAMA"},{"key":"1625_CR6","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1093\/jac\/dkt475","volume":"69","author":"EJ Giamarellos-Bourboulis","year":"2014","unstructured":"Giamarellos-Bourboulis EJ, Mylona V, Antonopoulou A, Tsangaris I, Koutelidakis I, Marioli A, et al. Effect of clarithromycin in patients with suspected Gram-negative sepsis: results of a randomized controlled trial. J Antimicrob Chemother. 2014;69:1111\u20138.","journal-title":"J Antimicrob Chemother"},{"key":"1625_CR7","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315:801\u201310.","journal-title":"JAMA"},{"key":"1625_CR8","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1172\/JCI115493","volume":"88","author":"C Munoz","year":"1991","unstructured":"Munoz C, Carlet J, Fitting C, Misset B, Bl\u00e9riot JP, Cavaillon JM. Dysregulation of in vitro cytokine production by monocytes during sepsis. J Clin Invest. 1991;88:1747\u201354.","journal-title":"J Clin Invest"},{"key":"1625_CR9","first-page":"35","volume":"131","author":"I Werra de","year":"2001","unstructured":"de Werra I, Zanetti G, Jaccard C, Chiol\u00e9ro R, Schaller MD, Yersin B, et al. CD14 expression on monocytes and TNF\u03b1 production in patients with septic shock, cardiogenic shock or bacterial pneumonia. Swiss Med Wkly. 2001;131:35\u201340.","journal-title":"Swiss Med Wkly"},{"key":"1625_CR10","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s40635-016-0078-1","volume":"4","author":"SS Santos","year":"2016","unstructured":"Santos SS, Carmo AM, Brunialti MKC, Machado FR, Azevedo LC, Assun\u00e7\u00e3o M, et al. Modulation of monocytes in septic patients: preserved phagocytic activity, increased ROS and NO generation, and decreased production of inflammatory cytokines. Intensive Care Med Exp. 2016;4:5.","journal-title":"Intensive Care Med Exp"},{"key":"1625_CR11","doi-asserted-by":"crossref","first-page":"e91886","DOI":"10.1371\/journal.pone.0091886","volume":"9","author":"P Severino","year":"2014","unstructured":"Severino P, Silva E, Baggio-Zappia GL, Brunialti MKC, Nucci LA, Rigato Jr O, et al. Patterns of gene expression in peripheral blood mononuclear cells and outcomes from patients with sepsis secondary to community acquired pneumonia. PLoS One. 2014;9:e91886.","journal-title":"PLoS One"},{"key":"1625_CR12","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1097\/00003246-199711000-00018","volume":"25","author":"C Martin","year":"1997","unstructured":"Martin C, Boisson C, Haccoun M, Thomachot L, Mege JL. Patterns of cytokine evolution (TNF-\u03b1 and IL-6) after septic shock, hemorrhagic shock, and severe trauma. Crit Care Med. 1997;25:1813\u20139.","journal-title":"Crit Care Med"},{"key":"1625_CR13","first-page":"680","volume":"5","author":"MC Morris","year":"2015","unstructured":"Morris MC, Gilliam EA, Li L. Innate immune programming by endotoxin and its pathological consequences. Trends Immunol. 2015;5:680.","journal-title":"Trends Immunol"},{"key":"1625_CR14","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.cyto.2013.03.028","volume":"62","author":"K Kopanakis","year":"2013","unstructured":"Kopanakis K, Tzepi IM, Pistiki A, Carrer DP, Netea MG, Georgitsi M, et al. Pre-treatment with low dose endotoxin prolongs survival from experimental lethal endotoxic shock: benefit for lethal peritonitis by Escherichia coli. Cytokine. 2013;62:382\u20138.","journal-title":"Cytokine"},{"key":"1625_CR15","doi-asserted-by":"crossref","first-page":"533","DOI":"10.4049\/jimmunol.0802189","volume":"183","author":"AF Vos de","year":"2009","unstructured":"de Vos AF, Pater JM, Van den Pangaart PS, de Kruif MD, Van \u2019t Veer C, Van der Poll T. In vivo lipopolysaccharide exposure of human blood leukocytes induces cross-tolerance to multiple TLR ligands. J Immunol. 2009;183:533\u201342.","journal-title":"J Immunol"},{"key":"1625_CR16","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1007\/s00134-008-1048-1","volume":"34","author":"D Payen","year":"2008","unstructured":"Payen D, Laukaszewicz AC, Belikova I, Faiver V, Gelin C, Russwurm S, et al. Gene profiling in human leukocytes during recovery from septic shock. Intensive Care Med. 2008;34:1371\u20136.","journal-title":"Intensive Care Med"},{"key":"1625_CR17","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1164\/rccm.201204-0645OC","volume":"186","author":"J Leentjens","year":"2012","unstructured":"Leentjens J, Kox M, Koch RM, Preijers F, Joosten LA, van der Hoeven JG, et al. Reversal of immunoparalysis in humans in vivo. Am J Respir Crit Care Med. 2012;186:838\u201345.","journal-title":"Am J Respir Crit Care Med"},{"key":"1625_CR18","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1164\/rccm.200903-0363OC","volume":"180","author":"C Meisel","year":"2009","unstructured":"Meisel C, Schefold JC, Pschowski R, Baumann T, Hetzger K, Gregor J, et al. GM-CSF to reverse sepsis-associated immunosuppression: a double-blind, randomized, placebo-controlled multicenter trial. Am J Respir Crit Care Med. 2009;180:640\u20138.","journal-title":"Am J Respir Crit Care Med"},{"key":"1625_CR19","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nri2970","volume":"11","author":"CL Mackall","year":"2009","unstructured":"Mackall CL, Fry TJ, Gress RE. Harnessing the biology of IL-7 for therapeutic application. Nat Rev Immunol. 2009;11:330\u201342.","journal-title":"Nat Rev Immunol"},{"key":"1625_CR20","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.4049\/jimmunol.0903151","volume":"184","author":"J Unsinger","year":"2010","unstructured":"Unsinger J, McGlynn M, Kasten KR, Hoekzema AS, Watanabe E, Muenzer JT, et al. IL-7 promotes T cell viability, trafficking, and functionality and improves survival in sepsis. J Immunol. 2010;184:3768\u201379.","journal-title":"J Immunol"},{"key":"1625_CR21","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1189\/jlb.0110037","volume":"88","author":"P Brahmamdam","year":"2010","unstructured":"Brahmamdam P, Inoue S, Unsinger J, Chang KC, McDunn JE, Hotchkiss RS. Delayed administration of anti-PD-1 antibody reverses immune dysfunction and improves survival during sepsis. J Leukoc Biol. 2010;88:233\u201340.","journal-title":"J Leukoc Biol"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-017-1625-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T07:58:28Z","timestamp":1498377508000},"score":1,"resource":{"primary":{"URL":"http:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/s13054-017-1625-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,9]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["1625"],"URL":"https:\/\/doi.org\/10.1186\/s13054-017-1625-1","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,9]]},"article-number":"48"}}